Report Categories
View AllRecent Articles
View All
Johnson Johnson JNJ Former Senior Pharma Finance Executive Darren Snellgrove Appointed CFO of Halozyme Therapeutics HALO
AMIX Autonomix EPS beats estimates by 397 but stock falls on zero revenue investors eye commercialization timeline
GRC GormanRupp posts 282 percent EPS beat over analyst estimates for Q1 2026 shares climb 324 percent
The market share dynamics in JELDWEN Holding JELD results Q4 2025 Earnings Fall Short
US Pushes American AI Integration in Asia Following TrumpXi Meeting Senior Official Says
CD Rates Hold Steady at Up to 4 APY as of May 24 2026
Tulsi Gabbard to Step Down as Trumps Intelligence Chief Amid Personal Health Crisis
MegaIPOs Signal Structural Challenges in Public Markets Analysis Suggests
SpaceX Scraps Starship Test Launch as IPO Filing Reveals Heavy Reliance on Rocket Program
Silver Prices Consolidate in Narrow Range Throughout the Week as Market Awaits Fresh Catalysts
MCRI Q1 2026 Earnings Strong EPS Beat Drives Positive Market Sentiment
IQ Q1 2026 Earnings EPS Misses Estimates Stock Rises 66
MTVA Q1 2026 Earnings EPS Misses Estimates but Stock Surges 3415
MCRI Q1 2026 Earnings EPS Surges Past Estimates by 349
ALKS Q1 2026 Earnings EPS Surpasses Estimates Amid Revenue Disclosure Gap Stock Slips
Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings WiderThanExpected Loss as Clinical Pipeline Progresses
Nurix Therapeutics NRIX Edges Higher as Biotech Sector Focus Intensifies Key Levels in Play
Canterbury Park CPHC Holds Steady Near Resistance After Modest Gain
Enerpac Tool Group EPAC Holds Steady Near 3458 as Consolidation Continues
Wrap Technologies Inc WRAP Edges Higher Amid Low Volume Key Resistance in Focus
Euro Tech Holdings CLWT Surges 147 as Speculative Interest Builds